FFA
REGN icon

Farther Finance Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Farther Finance Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.16M Buy
1,534
+459
+43% +$347K 0.01% 1040
2026
Q2 		$671K Sell
1,075
-795
-43% -$541K 0.01% 1342
2026
Q1 		$1.45M Sell
1,870
-122
-6% -$93.4K 0.01% 789
2025
Q4 		$1.54M Buy
1,992
+513
+35% +$348K 0.02% 696
2025
Q3 		$832K Buy
1,479
+848
+134% +$479K 0.01% 824
2025
Q2 		$331K Buy
631
+3
+0.5% +$1.67K 0.01% 1126
2025
Q1 		$387K Buy
628
+55
+10% +$37.8K 0.01% 912
2024
Q4 		$409K Sell
573
-151
-21% -$127K 0.01% 670
2024
Q3 		$761K Buy
724
+53
+8% +$59K 0.03% 439
2024
Q2 		$710K Buy
671
+31
+5% +$30.1K 0.03% 375
2024
Q1 		$621K Buy
640
+4
+0.6% +$3.8K 0.04% 345
2023
Q4 		$558K Buy
636
+149
+31% +$123K 0.04% 327
2023
Q3 		$401K Buy
487
+190
+64% +$149K 0.06% 237
2023
Q2 		$213K Buy
297
+189
+175% +$146K 0.05% 302
2023
Q1 		$88.7K Buy
108
+2
+2% +$1.51K 0.03% 433
2022
Q4 		$76.5K Buy
+106
New +$78.2K 0.03% 387

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Farther Finance Advisors's REGN Position: Q3 2026 in Review

Farther Finance Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 43% in Q3 2026, buying an estimated $347K and bringing the position to 1,534 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #1040.

Farther Finance Advisors first reported a position in REGN in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.54M in Q4 2025. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Farther Finance Advisors held 1,534 shares of Regeneron Pharmaceuticals worth $1.16M as of Q3 2026.
  • Farther Finance Advisors bought 459 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $347K.
  • Regeneron Pharmaceuticals made up 0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1040 holding.
  • Farther Finance Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Regeneron Pharmaceuticals position peaked at $1.54M in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.